Weight Loss Medication UK: Injections and Tablets Compared

Weight loss medication UK guide from CuraPhyx Pharmacy
A clear 2026 guide to every licensed weight loss medication in the UK, including how each works, eligibility, results and side effects.

Choosing a **weight loss medication in the UK** can feel confusing. There are now weekly injections, daily tablets and older capsules, and each one works differently. The NHS offers some of them, while others are only available privately. This guide explains every licensed option in plain English. It covers how each medicine works, who may be eligible, typical results and the main side effects. It also explains why a prescriber must always check whether treatment is safe for you.

Weight loss medication UK options at a glance

Key takeaways

  • Licensed weight loss medication in the UK includes Mounjaro (tirzepatide), Wegovy (semaglutide) injections and tablets, Foundayo (orforglipron), liraglutide and orlistat.
  • All of these, apart from low-dose orlistat, are prescription-only medicines.
  • You also need to use each medicine alongside a reduced-calorie diet and more physical activity.
  • Eligibility depends mainly on your BMI and any weight-related health conditions.
  • The NHS and private services use different criteria, so you may qualify for one but not the other.
  • Above all, a qualified prescriber should review your health before supplying any medicine.

What Weight Loss Medication Is Available in the UK?

The UK now has more licensed options for weight management than ever before. However, they are not all the same. Some act on appetite hormones, while one simply stops your body absorbing some fat.

The main licensed medicines are:

  • **Mounjaro (tirzepatide):** a once-weekly injection that acts on two gut hormones, GIP and GLP-1.
  • **Wegovy (semaglutide) injection:** a once-weekly GLP-1 injection.
  • **Wegovy tablets (oral semaglutide):** a once-daily GLP-1 tablet, approved by the MHRA in June 2026.
  • **Foundayo (orforglipron):** a once-daily GLP-1 tablet, authorised by the MHRA in August 2026.
  • **Liraglutide:** a once-daily GLP-1 injection, sold under brand names such as Saxenda and as generic versions.
  • **Orlistat:** a capsule you take with meals that stops your gut absorbing some dietary fat.

Each weight loss medication in the UK has a licence for adults who also follow a reduced-calorie diet and stay active. In other words, the medicine is a support tool rather than a replacement for healthy habits.

How Each Weight Loss Medication in the UK Works

Understanding how a medicine works helps explain its benefits and its side effects. So, here is a simple overview.

GLP-1 medicines

GLP-1 is a hormone your gut releases after you eat. It tells your brain you are full. It also slows how quickly your stomach empties. GLP-1 medicines copy this hormone. As a result, many people feel less hungry and think about food less often. Semaglutide, liraglutide and orforglipron all work in this way.

Dual GIP and GLP-1 medicines

Tirzepatide acts on GLP-1 receptors too. In addition, it acts on receptors for a second gut hormone called GIP. Experts think this dual action explains why average weight loss in trials has been higher than with GLP-1 medicines alone. You can read more in our guide to how tirzepatide works.

Fat blockers

Orlistat works in a completely different way. It blocks an enzyme called lipase in your gut. Because of this, about a third of the fat you eat passes straight through your body. It does not affect appetite.

Weight Loss Medication UK Comparison Table

The table below gives a quick side-by-side view. Doses and details come from the official product information and NHS guidance.

MedicineHow it is takenHow it worksTypical dose steps
Mounjaro (tirzepatide)Weekly injectionGIP and GLP-12.5mg rising in 2.5mg steps to a maximum of 15mg
Wegovy injection (semaglutide)Weekly injectionGLP-10.25mg rising over 16 weeks to 2.4mg (7.2mg for some people)
Wegovy tablets (semaglutide)Daily tabletGLP-11.5mg, then 4mg, 9mg and 25mg
Foundayo (orforglipron)Daily tabletGLP-10.8mg rising in monthly steps to 17.2mg
LiraglutideDaily injectionGLP-10.6mg rising weekly to 3mg
OrlistatCapsule with mealsBlocks fat absorption120mg (prescription) or 60mg (pharmacy) up to three times a day

Your prescriber also decides which dose you start on and how quickly it goes up. Never change your dose on your own.

Mounjaro (Tirzepatide)

Mounjaro is a once-weekly injection given with a pre-filled KwikPen. Treatment starts at 2.5mg for four weeks. After that, the dose usually rises to 5mg. Then, your prescriber can increase it by 2.5mg at least four weeks apart, up to a maximum of 15mg.

In the SURMOUNT-1 trial, adults without diabetes lost an average of 15% to 21% of their body weight over 72 weeks, depending on the dose. By comparison, people taking a placebo lost about 3%. However, results vary a lot from person to person.

The most common side effects are nausea, diarrhoea, vomiting, constipation and stomach pain. Because these are usually mild to moderate, they tend to ease over time. For a deeper look, see our guide to what Mounjaro is and how it works, plus our Mounjaro vs Wegovy comparison.

Wegovy (Semaglutide) Injections and Tablets

You inject Wegovy once a week. The dose builds up slowly over 16 weeks to a maintenance dose of 2.4mg. Since January 2026, the MHRA has also authorised a higher 7.2mg dose. It is only for adults with a BMI of 30 or more who have already been on 2.4mg for at least four weeks. Then, in April 2026, it approved a single-dose 7.2mg pen.

In the STEP 1 trial, adults lost about 15% of their body weight on average over 68 weeks. People taking a placebo lost around 2%.

The MHRA approved Wegovy tablets in June 2026. You take them once a day on an empty stomach with a small sip of water. You then wait at least 30 minutes before eating, drinking or taking other medicines. The dose rises from 1.5mg to 4mg, 9mg and then 25mg, with at least a month at each step. At the time of writing, the tablets are only available privately and not on the NHS.

Foundayo (Orforglipron)

Foundayo is a newer GLP-1 tablet. The MHRA authorised it in August 2026 for weight management and for type 2 diabetes. Unlike Wegovy tablets, you can take it at any time of day, with or without food and water.

Treatment starts at 0.8mg once daily. It then rises through 2.5mg, 5.5mg, 9mg and 14.5mg to 17.2mg, with at least a month at each step. The most common side effects are nausea, constipation, diarrhoea, vomiting, indigestion and stomach pain.

Foundayo is not currently available on the NHS. However, NICE plans to assess it, and that review will decide whether the NHS can use it.

Liraglutide

Liraglutide was one of the first GLP-1 medicines licensed for weight management. However, you inject it once a day rather than once a week. The dose increases weekly from 0.6mg to a maintenance dose of 3mg.

Generic versions are now available. Even so, prescribers now use liraglutide less often than they once did. This is because weekly options are more convenient for many people and have shown larger average weight loss in trials.

Orlistat

Orlistat is the longest-established weight loss medicine in the UK. The 120mg capsule is prescription-only. You can also buy a lower 60mg strength from a pharmacy after a conversation with the pharmacist.

You take one capsule with each main meal that contains fat, up to three times a day. If a meal contains no fat, or you skip a meal, you skip the dose. A low-fat diet is essential. Otherwise, side effects such as oily stools, wind and urgent bowel movements are much more likely.

Orlistat can reduce the absorption of some vitamins. That’s why a multivitamin taken at bedtime is often recommended. In addition, severe diarrhoea can make the contraceptive pill less effective, so you may need extra precautions.

Who Can Get Weight Loss Medication in the UK?

Eligibility depends on your body mass index (BMI) and your health. First, you can check your BMI with the NHS BMI calculator. However, a prescriber will also look at your medical history, other medicines and any weight-related conditions.

Licensed criteria for private treatment

For most weight loss medication in the UK, the licence covers adults with:

  • a BMI of 30 or more, or
  • a BMI of 27 or more plus at least one weight-related condition, such as high blood pressure, raised cholesterol, sleep apnoea, heart disease, prediabetes or type 2 diabetes.

Orlistat has a slightly different threshold of 28 or more with risk factors. Lower BMI thresholds are often used for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds. This is because health risks can rise at a lower BMI in these groups.

NHS criteria

NHS criteria are stricter. For example, NICE recommends Mounjaro on the NHS for adults with a BMI of at least 35 and at least one weight-related condition. Because demand is so high, NHS England is rolling it out in phases over several years.

The first group, from June 2025, was people with a BMI of 40 or more and at least four of five named conditions. From June 2026, this widened to people with a BMI of 35 to 39.9 and at least four conditions. Meanwhile, the NHS mainly offers Wegovy injections through specialist weight management services. Our guide to Mounjaro eligibility criteria explains the NHS phases in more detail.

Side Effects of Weight Loss Medication in the UK

Like all medicines, these can cause side effects. With GLP-1 and dual-action medicines, the most common are:

  • feeling or being sick
  • diarrhoea or constipation
  • stomach pain, bloating, wind or indigestion
  • reduced appetite, tiredness or dizziness

These are usually worst when you first start or increase your dose. Eating smaller meals, stopping when you feel full and avoiding very fatty food can help.

Less often, more serious problems can occur. These include gallstones, dehydration that affects the kidneys and inflammation of the pancreas (pancreatitis). In January 2026, the MHRA strengthened its warning about pancreatitis after rare reports of severe and fatal cases. Get urgent medical help if you develop severe stomach pain that does not go away, especially if it spreads to your back.

Who Should Not Take These Medicines?

Weight loss injections and GLP-1 tablets are not suitable for everyone. For instance, you should not use them during pregnancy or while breastfeeding. You should also stop them well before trying for a baby. The gap is one month for tirzepatide and two months for semaglutide.

Your prescriber will take extra care if you have had pancreatitis, gallbladder disease, severe stomach or bowel problems, diabetic eye disease or an eating disorder. They will also check how a medicine might affect others you take. For example, Mounjaro can make the contraceptive pill less effective, especially in the first weeks and after each dose increase.

How to Get Weight Loss Medication in the UK Safely

Overall, there are two main routes. You can ask your GP whether you meet NHS criteria. Alternatively, you can use a regulated private service, such as an online pharmacy. Our guide explains how an online consultation works step by step.

Whichever route you choose, a prescriber must assess you first. The MHRA warns people never to buy weight loss injections from beauty salons, social media or unregulated websites. In fact, the MHRA has found fake and unlicensed products in the UK. Some contained the wrong dose or no active ingredient at all.

Finally, price is another factor. Private costs vary by medicine and dose, so it helps to understand what affects the cost before you start.

Frequently Asked Questions

Which weight loss medication in the UK works best?

On average, tirzepatide has produced the largest weight loss in trials. In SURMOUNT-5, people on tirzepatide lost 20.2% of their body weight, compared with 13.7% on semaglutide, over 72 weeks. Still, the best medicine is the one that is safe and suitable for you.

Can I buy weight loss medication in the UK without a prescription?

No, apart from orlistat 60mg, which you can buy from a pharmacy without a prescription. Otherwise, every option needs a prescription after a proper health assessment.

Is weight loss medication in the UK available on the NHS?

Yes, for some people. For example, a GP can prescribe orlistat. In addition, the NHS is rolling out Mounjaro through GPs and specialist services in phases. Wegovy injections are mainly available through specialist weight management services. Wegovy tablets and Foundayo are not currently offered on the NHS.

How long do I need to take it?

Many people need long-term treatment to keep weight off. For Mounjaro, your prescriber should review progress after about six months on the highest dose you can tolerate. For Wegovy, the check comes after six months of treatment, and NHS use is limited to 2 years. In both cases, if you have lost less than 5% of your starting weight, they will discuss whether to continue.

What happens if I stop?

Weight regain is common after stopping. In SURMOUNT-4, people who switched to a placebo regained a large part of the weight they had lost. That’s why lasting changes to diet and activity matter so much.

Summary

There is now a wide choice of weight loss medication in the UK. Weekly injections such as Mounjaro and Wegovy have shown the largest average results. Meanwhile, new daily tablets offer a needle-free option, and orlistat remains available for people who prefer a fat blocker. Every option works best alongside a healthier diet and regular activity. Above all, a prescriber should check that any treatment is safe for you first.

Why Choose CuraPhyx Pharmacy?

CuraPhyx Pharmacy is a UK pharmacy built around safe, professional care. If you’re thinking about weight loss medication, this is what you can expect from us:

  • First, a qualified pharmacist prescriber reviews every request for a prescription medicine.
  • We check your answers, weight and medical history carefully before making any decision.
  • Medicines only leave the pharmacy after clinical approval. If treatment isn’t right for you, we’ll explain why and won’t supply it.
  • We send approved orders across the UK in discreet packaging.
  • Our team is also happy to help with questions at info@curaphyx.co.uk.

You can find out more about how our weight loss service works, including the checks involved, before you decide whether it’s right for you.

Sources and Further Reading

We checked this article against the following sources in October 2026:

This article is for general information only. It doesn’t replace advice from your GP, pharmacist or prescriber. Mounjaro is a prescription-only medicine, so a prescriber must decide whether it’s suitable for you. Always read the patient information leaflet that comes with your medicine. Last reviewed: October 2026.

Share the Post:

Related Posts